Nama Insights

Moderna Inc (MRNA)

Healthcare · Biotechnology · NASDAQ

S&P 500
Moderna Inc (MRNA) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $72.88B and a free-cash-flow yield of -2.9%. Over the most recent reported fiscal year, revenue declined 39.9%.
Market cap$72.88B
Trailing P/E
FCF yield-2.9%
Revenue growth (YoY)-39.9%
EPS growth (YoY)
FCF/share growth (YoY)
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Explore live MRNA data on Nama Insights →

Recent Congressional trades

Moderna Inc trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Maria Elvira Salazar House Sell $1,001 - $15,000 Sep 9, 2026
Rob Bresnahan House Sell $1,001 - $15,000 May 8, 2025
Rob Bresnahan House Buy $1,001 - $15,000 Mar 27, 2025
Julie Johnson House Sell $1,001 - $15,000 Feb 12, 2025
Josh Gottheimer House Sell $1,001 - $15,000 Mar 7, 2024
Josh Gottheimer House Sell $1,001 - $15,000 Oct 15, 2023
Daniel Goldman House Sell $50,001 - $100,000 Aug 13, 2023